No image
Inquiry Submitted Successfully

Glimepiride, Pioglitazone & Metformin HCL Tablets

  • Product Name : Glimepiride, Pioglitazone & Metformin HCL Tablets
  • Trade Name: Triexer, Zoryl MP Forte, Piomed MG, Amaryl MP
  • Available Strength : 1mg + 15mg + 500mg
  • Packing : 10X10 Tablets/Box
  • Pack Insert/Leaflet : Yes
  • Therapeutic use : Anti Diabetic
  • Production Capacity : 10 million tablet/month

Description

What is Glimepiride Metformin Pioglitazone?

Glimepiride Metformin Pioglitazone Tablet is a medicine that is used for the treatment of Type 2 Diabetes Mellitus, Maturity Onset Diabetes, Polycystic Ovary Syndrome, Lower Blood Glucose In Adults with Type 2 Diabetes Mellitus and other conditions.

Glimepiride Metformin Pioglitazone Tablet contains Glimepiride, Metformin, and Pioglitazone as active ingredients.

Glimepiride Metformin Pioglitazone Tablet works by increasing the amount of insulin released by the pancreas; decreasing the amount of glucose and controls the amount of glucose in the blood; helping the body make better use of insulin by decreasing the glucose output;

Detailed information related to Glimepiride MEtformin Pioglitazone Tablet's uses, composition, dosage, side effects and reviews is listed below.

 

Glimepiride Metformin Pioglitazone Tablet Uses

Glimepiride Metformin Pioglitazone Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

·         Type 2 Diabetes Mellitus

·         Maturity Onset Diabetes

·         Polycystic Ovary Syndrome

·         Lower Blood Glucose In Adults With Type 2 Diabetes Mellitus

 

Glimepiride Metformin Pioglitazone Tablet Working, Mechanism of Action and Pharmacology

Glimepiride Metformin Pioglitazone Tablet improves the patient's condition by performing the following functions:

·         Increasing the amount of insulin released by the pancreas.

·         Decreasing the amount of glucose and controls the amount of glucose in the blood.

·         Helping the body make better use of insulin by decreasing the glucose output.

 

Glimepiride Metformin Pioglitazone Tablet - Composition and Active Ingredients

Glimepiride Metformin Pioglitazone Tablet is composed of the following active ingredients (salts)

·         Glimepiride (1 MG)

·         Metformin (500 MG)

·         Pioglitazone (15 MG)

Please note that this medicine may be available in various strengths for each active ingredient listed above.

 

Glimepiride Metformin Pioglitazone Tablet - Side-effects

The following is a list of possible side effects that may occur from all constituting ingredients of Glimepiride Metformin Pioglitazone Tablet. This is not a comprehensive list. These side effects are possible, but do not always occur. Some of the side effects may be rare but serious. Consult your doctor if you observe any of the following side effects, especially if they do not go away.

·         Deficiency Of Red Blood Cells

·         Restlessness

·         Low Blood Sugar Level

·         Headache

·         Abnormal Blood Counts

·         Problems With Sleeping

 

Glimepiride Metformin Pioglitazone Tablet - Precautions & How to Use

Before using this drug, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below.

·         Be careful while using it with insulin or renal hypoglycaemics

·         Blurred vision

·         Check the blood sugar regularly

·         Consult a doctor if you have any mental confusion, persistent abdominal pain, dark urine, yellowing of skin/eyes or easy bruising

·         Consult a doctor if you have oedema, congestive heart failure, hepatic dysfunction, jaundice, anaemia

·         Diabetic ketoacidosis

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.

×